Regulated cell death in age-related macular degeneration: Regulatory mechanisms and therapeutic potential

Le-Le Zhang1, Jia-Mei Yu2, Zhong-Xi Fan3

  • 1School of Basic Medical Sciences, Chengdu University, Chengdu, 610106, China.

PubMed

Insights

Regulated cell death pathways contribute to age-related macular degeneration (AMD) progression. Targeting these pathways offers new therapeutic strategies for AMD treatment and prevention.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pathogenesis of Age-related Macular Degeneration

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults.
  • Oxidative stress, inflammation, and retinal pigment epithelium injury are key factors in AMD pathogenesis.
  • Regulated cell death pathways are crucial in cellular responses to stress and disease progression.

Purpose of the Study:

  • To review and analyze the relationship between regulated cell death and AMD.
  • To examine the therapeutic potential of targeting regulated cell death pathways for AMD.
  • To highlight promising future therapeutic strategies for AMD treatment and prevention.

Main Methods:

  • Comprehensive literature review of recent advancements.
  • Analysis of the role of various regulated cell death pathways (apoptosis, ferroptosis, pyroptosis, necroptosis, autophagy) in AMD.
  • Evaluation of therapeutic strategies targeting these pathways.

Main Results:

  • Several regulated cell death pathways are implicated in the progression of AMD through retinal pigment epithelium cell death.
  • Understanding these pathways opens new avenues for therapeutic interventions.
  • Targeting specific cell death mechanisms shows promise for AMD treatment.

Conclusions:

  • Regulated cell death pathways are significant contributors to AMD pathogenesis.
  • Targeting these pathways represents a promising therapeutic avenue for AMD.
  • Further research into these pathways could lead to novel prevention and treatment strategies for AMD.